Meet the leadership team that's helping transform spine surgery and beyond, and helping change patient lives every day.
Meet the leadership team that's helping transform spine surgery and beyond, and helping change patient lives every day.
Chairman and Chief Executive Officer
Greg Lucier serves as our Chairman and Chief Executive Officer.
Prior to this role, Mr. Lucier served as Chairman and CEO of Life Technologies Corporation for eleven years. Mr. Lucier was heading Life Technologies Corporation during the acquisition by Thermo Fisher Scientific in 2013 for $15.6 billion – one of the largest Life Sciences acquisitions to date. Before that Mr. Lucier served as President, Medical Information Technologies/GE Healthcare, overseeing the networking of medical electronic devices, digital imaging and clinical information systems with revenues of $1.8 billion. He was promoted by the GE Board to an officer of General Electric Corporation to serve as Vice President Global Services, GE Healthcare, the company’s $2 billion healthcare services business.
In addition to serving on the Board of NuVasive, he is a member of the Board of Directors for Catalent, Inc. and Invuity, Inc.
Mr. Lucier received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School.
Executive Vice President and Chief Financial Officer, Head of Strategy and Corporate Integrity
Quentin Blackford serves as our Executive Vice President and Chief Financial Officer, Head of Strategy and Corporate Integrity.
His prior roles at NuVasive include Chief Financial Officer; Executive Vice President of Finance and Investor Relations; Vice President of Finance; and Corporate Controller. Mr. Blackford has more than 17 years of experience in the healthcare industry, including as the Director of Finance and Controller for Zimmer’s Dental Division and leading the global corporate financial planning and analysis function at Zimmer. He obtained his Certified Public Accounting license after receiving dual Bachelor of Science degrees in Accounting and Business Administration, with an emphasis in Accounting, from Grace College.
Executive Vice President, External Affairs and Corporate Marketing
Carol Cox serves as our Executive Vice President, External Affairs and Corporate Marketing and is responsible for leading NuVasive’s external communications efforts.
Her prior roles include Senior Vice President, External Affairs at Sanford-Burnham Medical Research Institute; Senior Vice President of External Affairs and Corporate Communications at Life Technologies; Vice President of Investor Relations at CareFusion Corporation; and Senior Vice President for Global Corporate Communications and Investor Relations at Barr Pharmaceuticals. Ms. Cox holds a bachelor’s of arts degree in Foreign Affairs from the University of Virginia and a certificate in Investor Relations from The University of Connecticut School of Business.
President and Chief Operating Officer
Jason Hannon serves as our President and Chief Operating Officer.
His previous roles include NuVasive’s Executive Vice President, International from July 2015 to September 2016, Executive Vice President, Corporate Development and General Counsel from January 2010 to July 2015 and previously was the Company’s Senior Vice President, Corporate Development and General Counsel. Mr. Hannon’s background includes the practice of corporate and transactional law, specializing in mergers and acquisitions, public and private financing, joint ventures, licensing arrangements and corporate governance matters. Mr. Hannon received a B.A. from the University of California, Berkeley, and a J.D. from Stanford Law School.
Chief Information Officer
Johnson Lai serves as our Chief Information Officer.
His prior roles include Vice President of IT at Thermo Fisher Scientific; executive member of the integration management team that governed the integration of Life Technologies into Thermo Fisher Scientific; senior IT leader at Life Technologies delivering IT projects, including a global ERP, e-commerce and IT integration of companies acquired; and global IT leader for Abbott Vascular. Mr. Lai has a Bachelor of Science in Managerial Economics from the University of California at Davis and a Master of Business Administration with an emphasis in MIS, Accounting & Finance from the University of California at Davis.
Executive Vice President, Global Human Resources, Integrations, Real Estate and Internal Communications
Pete Leddy, Ph.D., serves as our Executive Vice President, Global Human Resources, Integrations, Real Estate and Internal Communications, after serving as a member of the Company’s Board of Directors from 2011 to July 2015.
His prior roles include Chief Human Resources Officer at Life Technologies; several senior management positions with Dell Incorporated; Executive Vice President for Human Resources at Promus Hotel Corporation (Doubletree, Embassy Suites); and a variety of executive and human resource positions at PepsiCo. Dr. Leddy received his B.A. in Psychology from Creighton University and his M.S. and Ph.D. degrees in industrial/organizational psychology from the Illinois Institute of Technology.
President, U.S. Commercial
Matt Link serves as our President, U.S. Commercial and is responsible for NuVasive’s commercial strategies, including broad efforts to integrate the Company’s sales, service and specialized customer marketing programs.
His prior roles at NuVasive include President, U.S. Sales and Service responsible for the leadership of all U.S. field personnel under a combined sales and service organization structure; Executive Vice President of U.S. Sales; Senior Vice President of Sales for the Company’s U.S. Eastern region; and several regional sales positions with DePuy Orthopedics and DePuy Spine. Mr. Link received a BSEd in Physical Education and Sports Medicine from the University of Virginia.
Patrick Miles has served as our Vice Chairman since September 2016 and has served as a member of NuVasive’s Board of Directors since August 2016.Mr. Miles is responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development.
Prior to that, he served as the Company’s President and Chief Operating Officer from February 2015 to September 2016; President of Global Products and Services from October 2011 to January 2015; President of the Americas from January 2010 to September 2011; Executive Vice President of Product Marketing and Development from January 2007 to December 2009; Senior Vice President of Marketing from December 2004 to January 2007; and Vice President, Marketing from January 2001 to December 2004. Mr. Miles has more than 25 years of experience in the orthopedic industry, including prior roles with Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.
CEO of NuVasive Specialized Orthopedics™, Inc.
Ed Roschak serves as our CEO of NuVasive Specialized Orthopedics, Inc.
Previously, he served as President and Chief Executive Officer, and on the board of directors, of Ellipse Technologies, Inc. Mr. Roschak’s prior roles include Ellipse’s Chief Operating Officer; Senior Vice President of Research and Development at Broncus Technologies, Inc. completing the spin-off of Asthmatx which was later acquired by Boston Scientific; and several positions at Hewlett-Packard and Guidant following the acquisition of Origin Medsystems. Mr. Roschak received a B.S. in mechanical engineering from the University of California, Santa Barbara and an M.B.A. from the University of Oregon.
Executive Vice President, General Counsel and Corporate Secretary
Joan Stafslien, Esq. serves as our Executive Vice President, General Counsel and Corporate Secretary.
Her previous roles include General Counsel, Corporate Secretary and Chief Compliance Officer at CareFusion; Segment General Counsel of Cardinal Health’s Clinical Technologies and Services; and Deputy General Counsel and Assistant Secretary of Alaris Medical Systems. Prior to joining Alaris, Ms. Stafslien was in private practice with Brobeck, Phleger & Harrison. Ms. Stafslien serves on the advisory board of the Chemical and Biological Engineering Department of Northwestern University and received a JD from University of Wisconsin Law School and a B.S. in Chemical Engineering from Northwestern University.
Vickie L. Capps has served as a member of our Board of Directors since June 2015. From July 2002 to December 2013, Ms. Capps served as the Chief Financial Officer of DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management. Prior to joining DJO Global, she served as the Chief Financial Officer of several other public and private companies. Earlier in her career, she served as a senior audit and accounting professional at Ernst & Young LLP. Ms. Capps is a member of the Senior Advisory Board of Consonance Capital Partners and serves on the board of its portfolio company, Enclara Pharmacia. She also serves on the board of directors and as chair of the audit committees of Otonomy, Inc. and Connecture, Inc. Ms. Capps is a California Certified Public Accountant and was recognized as CFO of the Year by the San Diego Business Journal in 2009 and 2010. She earned a bachelor’s degree in business administration/accounting from San Diego State University.
Peter C. Farrell, Ph.D., AM has served as a member of our Board of Directors since January 2005. Dr. Farrell was founding Chairman and Chief Executive Officer of ResMed, Inc., a leading developer and manufacturer of medical equipment for the diagnosis and treatment of sleep-disordered breathing. Dr. Farrell has been a Director and Chairman of the Board of ResMed since its inception in June 1989. He served as Chief Executive Officer of ResMed from 1990 to 2007 and again from February 2011 until March 2013. Dr. Farrell holds bachelor’s and master’s degrees in Chemical Engineering from the University of Sydney and the Massachusetts Institute of Technology, a Ph.D. in Bioengineering from the University of Washington, Seattle, and a Doctor of Science from the University of New South Wales for research related to dialysis and renal medicine.
Robert F. Friel has served as a member of our Board of Directors since February 2016. Mr. Friel currently serves as Chairman, Chief Executive Officer and President of PerkinElmer, Inc., and has been one of the primary architects of the company’s transformation into a global technology leader focused on improving the health and safety of people and the environment. Prior to being appointed PerkinElmer’s President and Chief Executive Officer in February 2008 and Chairman in April 2009, he previously served as President and Chief Operating Officer of PerkinElmer and as Vice Chairman and President of PerkinElmer’s Life and Analytical Sciences unit. Prior to that, Mr. Friel served as Executive Vice President and Chief Financial Officer of PerkinElmer with responsibility for business development and information technology in addition to his oversight of finance functions. Previously, he held several senior management positions with AlliedSignal, Inc., now Honeywell International. Mr. Friel currently serves as a member of the board of directors of Xylem, Inc. Mr. Friel received a Bachelor of Arts degree in economics from Lafayette College and a Master of Science degree in taxation from Fairleigh Dickinson University.
Lesley H. Howe has served as a member of our Board of Directors since February 2004. Mr. Howe has more than 40 years of experience in accounting, finance, and business management within a variety of industries. During Mr. Howe’s 30-year career with KPMG Peat Marwick LLP, an international accounting and auditing firm, he was an audit partner and an area managing partner/managing partner of the Los Angeles office of KPMG. While there, Mr. Howe worked as an independent financial and business consultant, advising clients on acquisition due diligence and negotiation strategies, as well as financing strategies. Mr. Howe currently serves as a member of the board of directors of Obalon Therapeutics, Inc. Mr. Howe received a B.S. in Business Administration from the University of Arkansas.
Patrick Miles has served as our Vice Chairman since September 2016 and has served as a member of NuVasive’s Board of Directors since August 2016. Mr. Miles is responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Prior to that, he served as the Company’s President and Chief Operating Officer from February 2015 to September 2016; President of Global Products and Services from October 2011 to January 2015; President of the Americas from January 2010 to September 2011; Executive Vice President of Product Marketing and Development from January 2007 to December 2009; Senior Vice President of Marketing from December 2004 to January 2007; and Vice President, Marketing from January 2001 to December 2004. Mr. Miles has more than 25 years of experience in the orthopedic industry, including prior roles with Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.
Leslie V. Norwalk, Esq. has served as a member of our Board of Directors since May 2014. Ms. Norwalk serves as a Strategic Advisor and Strategic Counsel to Epstein Becker & Green, P.C., EBG Advisors, Inc., and National Health Advisors. Ms. Norwalk also serves as an advisor to three private equity firms: Warburg Pincus LLC, Peloton Equity, and Enhanced Equity Fund. Previously, Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services after serving as the agency’s Deputy Administrator and serving in the first Bush administration. Prior to serving the Bush Administration, Ms. Norwalk practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. Ms. Norwalk currently serves as a member of the board of directors of the following organizations: Endologix, Providence Service Corp., Abode Healthcare, HPOne, Linkwell Health and MedCircle. Ms. Norwalk also serves as Member of International Advisory Council at APCO Worldwide Inc. She earned a J.D. degree from the George Mason University School of Law and a bachelor’s degree, cum laude, in Economics and International Relations from Wellesley College.
Michael D. O’Halleran has served as a member of our Board of Directors since August 2016. Mr. O’Halleran currently serves as the executive chairman of Aon Benfield and senior executive vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O’Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with companies in the insurance industry. Mr. O’Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.
Donald J. Rosenberg has served as a member of our Board of Directors since February 2016. Since October 2007, Mr. Rosenberg has served as Executive Vice President, General Counsel and Corporate Secretary of QUALCOMM Incorporated, a world leader in 3G, 4G and next-generation wireless technologies. Prior to joining QUALCOMM, he served as Senior Vice President, General Counsel and Corporate Secretary of Apple Inc. Prior to that, he was Senior Vice President and General Counsel of IBM Corporation. Mr. Rosenberg has served as an adjunct professor of law at New York’s Pace University School of Law, where he taught courses in intellectual property and antitrust law. He is the immediate past National Co-Chairman of the Board of the Lawyers’ Committee for Civil Rights Under Law. He received a Bachelor of Science degree in mathematics from the State University of New York at Stony Brook and his Juris Doctor from St. John’s University School of Law.
Daniel J. Wolterman has served as a member of our Board of Directors since July 2015. Mr. Wolterman served as President and CEO of Memorial Hermann Health System, the largest not-for-profit health system in Southeast Texas, from 2002 until his retirement in 2016. Currently, Mr. Wolterman is sole owner and CEO of Wolterman Consulting, LLC. Wolterman Consulting, LLC provides strategic and operational consulting services to healthcare providers and other entities. He currently serves as a member of the boards of directors of the Greater Houston Partnership and Vizient, Inc. Mr. Wolterman is also an Adjunct Professor at The University of Texas School of Public Health. Mr. Wolterman earned a B.S. degree in Business Administration and a M.B.A. in Finance from the University of Cincinnati and a Master’s Degree in Healthcare Administration from Xavier University.